MEREO BIOPHARMA GROUP PLC

Ticker: MREO CUSIP: 589492107 Class: ADR

PRIMECAP MANAGEMENT CO/CA/'s Holding History (CIK: 0000763212)

Note: Option positions (PUT/CALL) are excluded.

Q3 2024
Shares 54,000 Value ($000) $222 Avg Close Range
Q2 2024
Shares 54,000 Value ($000) $194 Avg Close Range
Q1 2024
Shares 54,000 Value ($000) $178 Avg Close Range
Q4 2023
Shares 54,000 Value ($000) $125 Avg Close Range
Q3 2023
Shares 79,000 Value ($000) $102 Avg Close Range
Q2 2023
Shares 157,700 Value ($000) $208 Avg Close Range
Q1 2023
Shares 296,530 Value ($000) $210 Avg Close Range
Q4 2022
Shares 297,230 Value ($000) $223 Avg Close Range
Q3 2022
Shares 314,760 Value ($000) $271 Avg Close Range
Q2 2022
Shares 321,660 Value ($000) $360 Avg Close Range
Q1 2022
Shares 330,900 Value ($000) $371 Avg Close Range
Q4 2021
Shares 332,200 Value ($000) $532 Avg Close Range
Q3 2021
Shares 339,600 Value ($000) $822 Avg Close Range
Q2 2021
Shares 488,938 Value ($000) $1,550 Avg Close Range
Q1 2021
Shares 489,100 Value ($000) $1,648 Avg Close Range
Q4 2020
Shares 489,100 Value ($000) $1,751 Avg Close Range
Q3 2020
Shares 489,100 Value ($000) $1,281 Avg Close Range
Q2 2020
Shares 489,100 Value ($000) $1,497 Avg Close Range
Q1 2020
Shares 543,375 Value ($000) $560 Avg Close Range
Q4 2019
Shares 601,762 Value ($000) $1,974 Avg Close Range
Q3 2019
Shares 683,356 Value ($000) $1,982 Avg Close Range
Q2 2019
Shares 696,110 Value ($000) $1,671 Avg Close Range